Medicine
Betamethasone dipropionate and Clotrimazole 0.5 mg/10 mg per mL lotion
Betamethasone dipropionate and Clotrimazole 0.5 mg/10 mg per mL lotion is a generic prescription medicine for topical use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F) in the upright position only,.
Key facts
- Active ingredient (INN)
- Betamethasone dipropionate and Clotrimazole
- Brand
- Sold under the generic name
- Strength
- 0.5 mg/10 mg per mL
- Dosage form
- Lotion
- Route
- Topical
- Packs
- 1 bottle
- Manufacturer
- Sun Pharmaceutical IndustriesIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F) in the upright position only,.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 July 2004
- Identifiers
- RxCUI 308715DailyMed set ID e4e9f244-4a85-4c0d-9917-93182c4a6e87NDC 51672-1308Application ANDA076493
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 30 mL in 1 bottle | 51672-1308-3 | Sun Pharmaceutical IndustriesIndia | 28 July 2004 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 July 1984 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Betamethasone dipropionate and Clotrimazole
Clinical summary
Betamethasone dipropionate and Clotrimazole is a fixed-dose combination of an azole antifungal and a corticosteroid indicated for the topical treatment of symptomatic inflammatory tinea pedis, among other approved uses. MedsAcross supplies Betamethasone dipropionate and Clotrimazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Betamethasone dipropionate and ClotrimazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Clotrimazole and Betamethasone Dipropionate prescribing information (E. Fougera) · U.S. National Library of Medicine, DailyMed
Need Betamethasone dipropionate and Clotrimazole 0.5 mg/10 mg per mL lotion for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.